Concerned that your diabetes could making you more vulnerable to dying from prostate cancer? Yes, diabetes sufferers should be concerned about a potential shorter life span, but not as of a result of prostate cancer (CaP). In the Journal of Clinical Oncology (September 10, 2008), Dr. Matthew Smith and his colleagues reported on the association [...]
There have been a number of articles that claim that older cancer patients report less distress than younger cancer patients report. However, this research has generally not sorted the differences among general distress, anxiety, and depression in older vs. younger survivors. Elson CJ, Weinberger MI, Balk E, Holland J, Breitbart W, Roth AJ. From the [...]
A study from Milan Italy look at the controversy, does the testosterone level achieved with androgen-deprivation therapy (ADT) increase the survival in men with metastatic prostate cancer? ADT comes with significant morbidity issues, so is there an adequate benefit from ADT (does it provide survival benefits) to balance out the negative side effects? This [...]
A post-surgery increase of PSA (usually three increases) is the definition for a prostate cancer recurrence. The best response after these increases is to radiate the prostate bed in hopes for stopping any stray cancer cells that had escaped prior to surgery. Using salvage radiation is the only remaining treatment modality that might allow a [...]
Stories abound about men who undergo prostate cancer surgery only to have the surgery halted when their doctor sees that the cancer has left the gland. The stories go that the doctor stops the surgery leaving the gland and any other visible tumors in place just as they found them. Current statistics indicate that one [...]
A multi-center Phase III study discussed at the 2009 meeting of the American Urological Association,[1] has demonstrated that the risk for bone fractures in men on androgen deprivation therapy (ADT) can be reduced by using toremifene (Acapodene). Men, fighting advanced prostate cancer, often receive long-term ADT, which along with other side effects will increase their [...]
Confirming a belief of many of us, new research has found that hormone therapy (endocrine therapy or ADT) is associated with a very large increased risk of developing various major heart problems. This research also tells us that some therapy options have a higher risk profile than others. At Europe's biggest cancer congress, ECCO 15 [...]
Advanced prostate cancer poses a deadly paradox for younger men (aged 35 to 44 years). Younger men diagnosed with advanced prostate cancer will have a shorter remaining life span than older men who develop the disease, despite the fact that in general younger men have a much lower risk of dying from prostate cancer. Daniel [...]
I have often hypothesized that stress can escalate the rate of prostate cancer progression, leading to earlier deaths. I work actively to find ways to eliminate stress from my immediate environment and from my life. I have told the story many times about two men who were members of my weekly Malecare prostate cancer support [...]
The September issue of The Journal of Nuclear Medicine published a study that shows that positron emission tomography (PET)/computer tomography (CT) scans using the imaging agent choline could detect recurring prostate cancer sooner than conventional imaging technologies in some men who have had prostatectomy. Men who elect to have a radical prostatectomy to treat prostate [...]
